reviewDrug Discovery TodayMay 22, 2015Closed access

Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies

RARenato A. Bauer

Eli Lilly (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

527
total citations
FWCI
20.61
Percentile
100%
References
100
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Drug
  • Pharmacology
  • Drug discovery
  • Covalent bond
  • Pharmacokinetics
  • Dosing
  • Pharmacodynamics
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.